EDESA BIOTECH, INC. Cash Equivalents, at Carrying Value
EDESA BIOTECH, INC. (EDSA) had Cash Equivalents, at Carrying Value of $7.09 million as of 2022-09-30, per its 10-K filed 2022-12-16.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:CashEquivalentsAtCarryingValue · last filed 2022-12-16
- 2022-09-30: Cash Equivalents, at Carrying Value $7.09M.
- 2021-09-30: Cash Equivalents, at Carrying Value $7.84M.
- 2019-03-31: Cash Equivalents, at Carrying Value $5.34M.
- 2018-12-31: Cash Equivalents, at Carrying Value $422.84K.
| Period end | Cash Equivalents, at Carrying Value |
|---|---|
| 2022-09-30 | $7.09M 10-K · filed 2022-12-16 |
| 2021-09-30 | $7.84M 10-K · filed 2021-12-28 |
| 2019-03-31 | $5.34M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $422.84K 10-Q · filed 2019-02-05 |
| 2018-09-30 | $506.48K 10-K · filed 2018-11-30 |
| 2018-06-30 | $3.99M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $504.20K 10-Q · filed 2019-05-08 |
| 2017-12-31 | $278.81K 10-Q · filed 2019-02-05 |
| 2017-09-30 | $723.30K 10-K · filed 2018-11-30 |
| 2017-06-30 | $2.61M 10-Q · filed 2018-08-08 |
| 2017-03-31 | $3.75M 10-Q · filed 2018-05-07 |
| 2016-12-31 | $1.34M 10-Q · filed 2018-02-07 |
| 2016-09-30 | $6.44M 10-K · filed 2017-12-01 |
| 2016-06-30 | $3.08M 10-Q · filed 2017-08-09 |
| 2016-03-31 | $0.00 10-Q · filed 2017-05-09 |
| 2015-12-31 | $0.00 10-Q · filed 2017-02-06 |
| 2015-09-30 | $0.00 10-K · filed 2017-12-01 |
| 2015-06-30 | $3.24M 10-Q · filed 2016-08-09 |
| 2015-03-31 | $108.54K 10-Q · filed 2016-05-09 |
| 2014-12-31 | $3.44M 10-Q · filed 2016-02-08 |
| 2014-09-30 | $2.87M 10-K · filed 2016-12-14 |
| 2014-08-31 | $2.95M 10-K · filed 2016-12-14 |
| 2013-08-31 | $1.62M 10-K · filed 2015-12-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |